Puraffinity raises $13.9m in Series A funding

This latest investment will allow Puraffinity to scale up its operations and transition from being an R&D focussed organisation to being a full commercial entity.

“As an advanced precision materials company, our long-term vision includes diversifying into new market segments and exploring broader applications for our adsorbent technology beyond PFAS-related solutions,” said Henrik Hagemann, Puraffinity’s CEO.

PFAS (Per-and polyfluoroalkylated substances) comprise of approximately 9000 different synthetic compounds that resist grease, oil, water, and heat. For over 60 years PFAS were used in the manufacture of numerous products which led to their widespread release into the environment.

Carbon-fluorine bonds in PFAS make them extremely resistant to natural degradation; they are hard to treat and, in many cases, conventional technologies cannot meet removal demands. Furthermore, PFAS have been connected to severe health effects, such as several types of cancer and compromised immune responses.

Pureaffinity's patented technology allows for the rapid development of high-capacity adsorbent materials, an approach that engineers the surface of raw materials using tailored molecular groups that trap PFAS compounds and removes them from the water.